The high APLN expression was not correlated with RFS in LGG patients without seizure history (p = 0.7572), with recurrent tumor (p = 0.1468), without targeted molecular therapy (p = 0.462), with astrocytoma (p = 0.7805), or with oligoastrocytoma (p = 0.0809; Figure S3). Here, APLN is linked to astrocytoma (excluding glioblastoma).